Completed

Website Tool for Reducing Burden in Dementia Care Partners with Dysphagia Challenges

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

WeCareToFeedDysphagia web tool

Behavioral
Who is being recruted

Caregiver Burden+16

+ Alzheimer Disease

+ Behavior

Over 18 Years
+8 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: October 2024
See protocol details

Summary

Principal SponsorNorthwell Health
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 8, 2024

Actual date on which the first participant was enrolled.

This clinical trial is exploring whether a new website tool, called WeCareToFeedDysphagia, can help reduce the feelings of stress and burden experienced by caregivers of people with Alzheimer's disease and related dementias who also have trouble swallowing, known as oropharyngeal dysphagia. The study is specifically looking at how the tool influences caregivers by measuring the strength of its effect on reducing their burden. The trial is important because it could lead to better support for caregivers, making their challenging roles more manageable, and it aims to determine if these findings could be applied in a larger study with more participants. In this study, caregivers are divided into two groups. One group uses the WeCareToFeedDysphagia tool, receiving three text reminders over a three-week period to engage with the tool. Both groups have access to contact information for a speech language pathologist for additional support. Participants will complete online surveys three times: when they join the study, one month after the patient leaves the hospital, and three months later. This will help researchers determine if the tool effectively eases caregivers' burdens and whether the study method can be applied on a larger scale.

Official TitleReducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal Dysphagia
NCT06557863
Principal SponsorNorthwell Health
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

80 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Caregiver BurdenAlzheimer DiseaseBehaviorMental DisordersBehavioral SymptomsBrain DiseasesCentral Nervous System DiseasesDeglutition DisordersDementiaDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesNervous System DiseasesOtorhinolaryngologic DiseasesPharyngeal DiseasesStress, PsychologicalNeurodegenerative DiseasesNeurocognitive DisordersTauopathies

Criteria

5 inclusion criteria required to participate
Self identifies as the primary care partner of an older adult patient (patient aged 65 years or older) with Alzheimer's disease and related dementias (AD/ADRD) and oropharyngeal dysphagia (OD) admitted to the Northwell Health medicine service

Care partner age 18 years or older

Designated as the legally authorized representative (LAR) or health care proxy (HCP), or designated by the LAR or HCP to participate

Proficient in English

Show More Criteria

3 exclusion criteria prevent from participating
Care partner of patient with a percutaneous feeding tube [i.e. percutaneous endoscopic gastrostomy (PEG) tube, percutaneous endoscopic jejunostomy (PEJ) used exclusively]

Care partner of patient who will not be discharged to the home or community setting (e.g., home, assisted living, independent living)

Care partner will not be involved with OD management (e.g. buying or making food, feeding, supervising) after hospital discharge

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants receive usual care from their medical team and receive contact information for speech-language pathology follow-up care. Participants will also receive access to the WeCareToFeedDysphagia web tool and receive text message reminders to use the tool.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Feinstein Institutes for Medical Research

Manhasset, United StatesOpen Feinstein Institutes for Medical Research in Google Maps
CompletedOne Study Center